Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Trading Update

22 Jan 2019 07:00

RNS Number : 6990N
Kier Group PLC
22 January 2019
 

22 January 2019

 

KIER GROUP PLC - TRADING UPDATE

 

Kier Group plc ("the Group"), a leading infrastructure services, buildings and developments & housing group, announces its trading update covering the period since its previous trading update of 16 November 2018. The Group will announce its half-year results on 21 March 2019.

 

Highlights include:

· On track to meet its FY19 expectations;

· Average month-end net debt of c.£370m (H2 FY18: £410m), reflecting the impact of the recent rights issue; and

· The Future Proofing Kier programme (the "FPK programme") is progressing well.

 

TradingThe Board is confident that the Group will meet its FY19 expectations, with the full-year results being weighted towards the second half of the financial year, as usual.

 

During the period, the Infrastructure Services and Buildings businesses won a number of new contract awards and now have 100% visibility of the forecast revenue for FY19 and an order book of more than £10bn.

 

Examples of recent key awarded contracts include:

· the renewal of a three-year c.£70m utility services contract in the south west of England;

· over £500m of regional building projects secured during November and December, including a major office development for Argent at King's Cross in London, a new research facility for the Pirbright Institute in Surrey, a flagship development for the Royal College of Art and a new hospital for Frimley Health NHS Foundation Trust; and

· being appointed to three lots on the North West Construction Hub three-year £1.5bn framework.

 

In the Developments & Housing businesses, we have experienced a stable housing market, evidenced by a current sales rate of 0.8 units per sales outlet per week (2018: 0.7). In property developments, we have sold all schemes which were forecast to be sold in the period, which highlights the strength of our regional development activities.

 

Future Proofing Kier programme

As previously reported, the costs of implementing the FPK programme in the first half of the financial year have exceeded the savings by £10m. The full-year FY19 position is still expected to be earnings and cashflow neutral and the programme is progressing well.

 

Balance Sheet

The Group's balance sheet at 31 December 2018 has been strengthened following the receipt of the £250m net cash proceeds of the recent rights issue and the Group remains on track to report a net cash position at the year-end (30 June 2019). As at 31 December 2018, the Group's net debt was c.£130m (31 December 2017: £239m), reflecting the rights issue proceeds and the acceleration of supply chain payments, as expected. The average month-end net debt for the six months ended 31 December 2018 was c.£370m, as compared with £410m for the six months ended 30 June 2018.

 

- ENDS -

 

For further information, please contact: 

Louise Turner-Smith, Kier investor relations

+44 (0)7976 790012

Kier press office

+44 (0)1767 355903

Nick Hasell, FTI Consulting

+44 (0)203 727 1340

 

 

Cautionary statement

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2018 for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGUGGGUPBPGG
Date   Source Headline
17th Dec 202010:53 amRNSResult of AGM
17th Dec 20207:00 amRNS2020 Annual General Meeting
24th Nov 202010:19 amRNSHolding(s) in Company
19th Nov 20202:06 pmRNSDirector/PDMR Shareholding
27th Oct 20209:40 amRNSDirector/PDMR Shareholding
26th Oct 20209:08 amRNSDirector/PDMR Shareholding
16th Oct 20201:30 pmRNSNotice of AGM
9th Oct 20201:30 pmRNSAnnual Financial Report
6th Oct 20209:07 amRNSHolding(s) in Company
30th Sep 20208:00 amRNSDirector/PDMR Shareholding
21st Sep 202011:44 amRNSDirector/PDMR Shareholding
18th Sep 20202:47 pmRNSHolding(s) in Company
17th Sep 20209:39 amRNSResults for the year ended 30 June 2020
17th Sep 20208:06 amRNSPublication of Full Year Results
7th Sep 20207:00 amRNSBoard Appointment
19th Aug 202010:18 amRNSDirector/PDMR Shareholding
7th Aug 20203:00 pmRNSDirector Declaration
5th Aug 20204:00 pmRNSHolding(s) in Company
5th Aug 20203:00 pmRNSHolding(s) in Company
23rd Jul 20209:34 amRNSHolding(s) in Company
22nd Jul 20209:30 amRNSHolding(s) in Company
21st Jul 202012:01 pmRNSDirector/PDMR Shareholding
9th Jul 20209:29 amRNSHolding(s) in Company
8th Jul 20209:15 amRNSHolding(s) in Company
1st Jul 20209:10 amRNSBlock listing Interim Review
1st Jul 20207:00 amRNSTrading update
22nd Jun 202010:01 amRNSDirector/PDMR Shareholding
8th Jun 20204:36 pmRNSHolding(s) in Company
5th Jun 20209:30 amRNSHolding(s) in Company
2nd Jun 202010:23 amRNSHolding(s) in Company
2nd Jun 20209:38 amRNSNotification of Change in Director’s Details
26th May 20208:51 amRNSHolding(s) in Company
22nd May 20209:17 amRNSHolding(s) in Company
22nd May 20207:00 amRNSBoard Change
19th May 20209:03 amRNSDirector/PDMR Shareholding
13th May 20209:28 amRNSHolding(s) in Company
7th May 20205:13 pmRNSHolding(s) in Company
22nd Apr 202012:00 pmRNSDirector/PDMR Shareholding
21st Apr 202010:01 amRNSHolding(s) in Company
17th Apr 20203:18 pmRNSHolding(s) in Company
1st Apr 202012:08 pmRNSSecond Price Monitoring Extn
1st Apr 202012:03 pmRNSPrice Monitoring Extension
31st Mar 20202:34 pmRNSNotification of Change of Director's Details
30th Mar 20207:01 amRNSBoard Changes
30th Mar 20207:00 amRNSCOVID-19 Update
25th Mar 202012:32 pmRNSHolding(s) in Company
20th Mar 20209:44 amRNSDirector/PDMR Shareholding
20th Mar 20207:00 amRNSDirector/PDMR Shareholding
20th Mar 20207:00 amRNSDirector/PDMR Shareholding
20th Mar 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.